Your browser doesn't support javascript.
loading
Administration of Enfortumab Vedotin after Immune-Checkpoint Inhibitor and the Prognosis in Japanese Metastatic Urothelial Carcinoma: A Large Database Study on Enfortumab Vedotin in Metastatic Urothelial Carcinoma.
Kawahara, Takashi; Hasizume, Akihito; Uemura, Koichi; Yamaguchi, Katsuya; Ito, Hiroki; Takeshima, Teppei; Hasumi, Hisashi; Teranishi, Jun-Ichi; Ousaka, Kimito; Makiyama, Kazuhide; Uemura, Hiroji.
Afiliação
  • Kawahara T; Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan.
  • Hasizume A; Department of Urology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0027, Japan.
  • Uemura K; Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan.
  • Yamaguchi K; Department of Urology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0027, Japan.
  • Ito H; Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan.
  • Takeshima T; Department of Urology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0027, Japan.
  • Hasumi H; Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan.
  • Teranishi JI; Department of Urology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0027, Japan.
  • Ousaka K; Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan.
  • Makiyama K; Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan.
  • Uemura H; Department of Urology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0027, Japan.
Cancers (Basel) ; 15(17)2023 Aug 23.
Article em En | MEDLINE | ID: mdl-37686503
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article